Excellerant (EXCL) 10-Q9 Aug 212021 Q3 Quarterly reportFinancial data

Company Profile

Cover

Cover - shares	9 Months Ended
Cover - shares	Jun. 30, 2021	Aug. 08, 2021
Cover [Abstract]
Entity Registrant Name	Excellerant, Inc.
Entity Central Index Key	0001786119
Document Type	10-Q
Amendment Flag	false
Current Fiscal Year End Date	--09-30
Entity Small Business	true
Entity Shell Company	true
Entity Emerging Growth Company	true
Entity Current Reporting Status	Yes
Document Period End Date	Jun. 30, 2021
Entity Filer Category	Non-accelerated Filer
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2021
Entity Ex Transition Period	true
Entity Common Stock Shares Outstanding		5,648,000
Document Quarterly Report	true
Document Transition Report	false
Entity Interactive Data Current	Yes
Entity File Number	333-234796
Entity Incorporation State Country Code	NV
Entity Tax Identification Number	98-1497791
Entity Address Address Line 1	54 Bl du Regent
Entity Address City Or Town	Brussels
Entity Address Country	BE
Entity Address Postal Zip Code	1000
City Area Code	32
Local Phone Number	27810118
Contact Personnel Email Address	excellerant@gmx.com

BALANCE SHEETS

BALANCE SHEETS - USD ($)	Jun. 30, 2021	Sep. 30, 2020
Current Assets
Escrow account	$ 0	$ 20,745
Prepaid expense	5,500	0
Total Current Assets	5,500	20,745
TOTAL ASSETS	5,500	20,745
Current Liabilities
Accounts payable and accrued liabilities	6,905	0
Accounts payable - related party	0	16,000
Director Loan	10,154	10,832
Total Current Liabilities	17,059	26,832
Total Liabilities	17,059	26,832
Stockholders' Deficit
Common stock, par value $0.0001; 75,000,000 shares authorized, 5,648,000 shares issued and outstanding	564	564
Additional paid-in capital	26,216	26,216
Accumulated deficit	(38,339)	(32,867)
Total Stockholders' Deficit	(11,559)	(6,087)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$ 5,500	$ 20,745

BALANCE SHEETS (Parenthetical)

BALANCE SHEETS (Parenthetical) - $ / shares	Jun. 30, 2021	Sep. 30, 2020
Stockholders' Deficit
Common Stock, Shares Authorized	75,000,000	75,000,000
Common Stock, Par or Stated Value Per Share	$ 0.0001	$ 0.0001
Common Stock, Shares Issued	5,648,000	5,648,000
Common Stock, Shares Outstanding	5,648,000	5,648,000

STATEMENT OF OPERATIONS (UNAUDI

STATEMENT OF OPERATIONS (UNAUDITED) - USD ($)	3 Months Ended		9 Months Ended
STATEMENT OF OPERATIONS (UNAUDITED) - USD ($)	Jun. 30, 2021	Jun. 30, 2020	Jun. 30, 2021	Jun. 30, 2020
OPERATING EXPENSES
General and administrative expenses	$ 9,204	$ 7,251	$ 35,304	$ 21,044
Total Operating Expenses	9,204	7,251	35,304	21,044
OTHER INCOME (EXPENSES)
Gain on extinguishment of debt	0	0	29,832	0
Total Other Income	0	0	29,832	0
Loss from operations	(9,204)	(7,251)	(5,472)	(21,044)
Provision for income taxes	0	0	0	0
NET LOSS	$ (9,204)	$ (7,251)	$ (5,472)	$ (21,044)
NET LOSS PER SHARE: BASIC AND DILUTED	$ 0	$ 0	$ 0	$ (0.01)
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING: BASIC AND DILUTED	5,648,000	3,398,088	5,648,000	2,995,646

STATEMENTS OF STOCKHOLDERS DEFI

STATEMENTS OF STOCKHOLDERS DEFICIT (UNAUDITED) - USD ($)	Total	Common Stock	Additional Paid-In Capital	Accumulated Deficit
Balance, shares at Sep. 30, 2019		3,000,000
Balance, amount at Sep. 30, 2019	$ (10,723)	$ 300	$ 0	$ (11,023)
Net loss	(3,313)	$ 0	0	(3,313)
Balance, shares at Dec. 31, 2019		3,000,000
Balance, amount at Dec. 31, 2019	(14,036)	$ 300	0	(14,336)
Balance, shares at Sep. 30, 2019		3,000,000
Balance, amount at Sep. 30, 2019	(10,723)	$ 300	0	(11,023)
Net loss	(21,044)
Balance, shares at Jun. 30, 2020		5,648,000
Balance, amount at Jun. 30, 2020	(787)	$ 564	26,216	(27,567)
Balance, shares at Dec. 31, 2019		3,000,000
Balance, amount at Dec. 31, 2019	(14,036)	$ 300	0	(14,336)
Net loss	(5,980)	$ 0	0	(5,980)
Shares issued for cash, shares		420,000
Shares issued for cash, amount	4,200	$ 42	4,158	0
Balance, shares at Mar. 31, 2020		3,420,000
Balance, amount at Mar. 31, 2020	(15,816)	$ 342	4,158	(20,316)
Net loss	(7,251)	$ 0	0	(7,251)
Shares issued for cash, shares		2,228,000
Shares issued for cash, amount	22,280	$ 222	22,058	0
Balance, shares at Jun. 30, 2020		5,648,000
Balance, amount at Jun. 30, 2020	(787)	$ 564	26,216	(27,567)
Balance, shares at Sep. 30, 2020		5,648,000
Balance, amount at Sep. 30, 2020	(6,087)	$ 564	26,216	(32,867)
Net loss	(20,800)	$ 0	0	(20,800)
Balance, shares at Dec. 31, 2020		5,648,000
Balance, amount at Dec. 31, 2020	(26,887)	$ 564	26,216	(53,667)
Balance, shares at Sep. 30, 2020		5,648,000
Balance, amount at Sep. 30, 2020	(6,087)	$ 564	26,216	(32,867)
Net loss	(5,472)
Balance, shares at Jun. 30, 2021		5,648,000
Balance, amount at Jun. 30, 2021	(11,559)	$ 564	26,216	(38,339)
Balance, shares at Dec. 31, 2020		5,648,000
Balance, amount at Dec. 31, 2020	(26,887)	$ 564	26,216	(53,667)
Net loss	24,532	$ 0	0	24,532
Balance, shares at Mar. 31, 2021		5,648,000
Balance, amount at Mar. 31, 2021	(2,355)	$ 564	26,216	(29,135)
Net loss	(9,204)	$ 0	0	(9,204)
Balance, shares at Jun. 30, 2021		5,648,000
Balance, amount at Jun. 30, 2021	$ (11,559)	$ 564	$ 26,216	$ (38,339)

STATEMENT OF CASH FLOWS (UNAUDI

STATEMENT OF CASH FLOWS (UNAUDITED) - USD ($)	9 Months Ended
STATEMENT OF CASH FLOWS (UNAUDITED) - USD ($)	Jun. 30, 2021	Jun. 30, 2020
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (5,472)	$ (21,044)
Adjustments to reconcile net loss to net cash from operating activities:
Gain on extinguishment of debt	(29,832)	0
Changes in operating assets and liabilities:
Prepaid expense	(5,500)	0
Accounts payable and accrued liabilities	9,905	9,000
Net cash used in operating activities	(30,899)	(12,044)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from issuance of common stock	0	26,480
Proceeds from director loan	10,154	8,609
Net cash provided by financing activities	10,154	35,089
Net change in cash and cash equivalents	(20,745)	23,045
Cash and cash equivalents - beginning of period	20,745	0
Cash and cash equivalents - end of period	0	23,045
Cash consists of:
Funds held in escrow	0	23,045
Supplemental Cash Flow Disclosures
Cash paid for interest	0	0
Cash paid for income taxes	0	0
Non-Cash Investing and Financing Activity:
Forgiveness of loans	$ 29,832	$ 0

ORGANIZATION AND BUSINESS OPERA

ORGANIZATION AND BUSINESS OPERATIONS	9 Months Ended
ORGANIZATION AND BUSINESS OPERATIONS	Jun. 30, 2021
ORGANIZATION AND BUSINESS OPERATIONS
NOTE 1 - ORGANIZATION AND BUSINESS OPERATIONS	NOTE 1 – ORGANIZATION AND BUSINESS OPERATIONS EXCELLERANT, INC. (“the Company “we,” “us” or “our”) was incorporated in the State of Nevada on May 30, 2019. Our company is planning to offer a broad range of health advisory and tour services: consulting services in the field of traditional and alternative medicine and medical technologies in China; helping our customers to choose a clinic for treatment; consulting customers and helping them to arrange the itinerary, by building a route, which includes clinics, hospitals and other medical institution; providing guide services to our potential clients. We also provide them with information concerning transportation, the cost of it, how it operates and what are the best medical institutions. We are going to provide our services both to legal entities and individuals. The company’s address is 302 Yayun Ave, Panyu, Guangzhou, Guangdong 510000, China.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	9 Months Ended
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	Jun. 30, 2021
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying unaudited interim financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included. Operating results for the nine months ended June 30, 2021 are not necessarily indicative of the results that may be expected for the year ending September 30, 2021. Notes to the unaudited interim financial statements that would substantially duplicate the disclosures contained in the audited financial statements for fiscal year 2020 have been omitted. This report should be read in conjunction with the audited financial statements and the footnotes thereto for the fiscal year ended September 30, 2020 included in the Company’s Form 10-K as filed with the Securities and Exchange Commission on November 20, 2020. Development Stage Company The Company is a development stage company as defined in ASC 915 “Development Stage Entities.” The Company is devoting substantially all of its efforts on establishing the business and its planned principal operations have not commenced. All losses accumulated since inception has been considered as part of the Company's development stage activities. The Company has elected to adopt application of Accounting Standards Update No. 2014-10, Development Stage Entities (Topic 915): Elimination of Certain Financial Reporting Requirements. Upon adoption, the Company no longer presents or discloses inception-to-date information and other remaining disclosure requirements of Topic 915. Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates. Cash and Cash Equivalents The Company considers all highly liquid investments with the original maturities of three months or less to be cash equivalents. During the year ended September 30, 2020, the Company entered a Trust Agreement with the director and set up Related Party Trust Account for holding funds in relation to issuing shares for stock consideration of $20,745. During the nine months ended June 30, 2021, all the funds held in escrow has been utilized and the Company did not have any fund held in the escrow account as of June 30, 2021. Fair Value of Financial Instruments ASC 820 “ Fair Value Measurements and Disclosures These tiers include: Level 1: defined as observable inputs such as quoted prices in active markets; Level 2: defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and Level 3: defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions. The carrying value of accounts payable and accrued liabilities, accrued interest, current portion of long-term debt, other party loan and loan from director approximates its fair value due to their short-term maturity. Revenue Recognition The Company recognizes revenue from its contracts with customers in accordance with ASC 606 – Revenue from Contracts with Customers. Revenue related to contracts with customers is evaluated utilizing the following steps: (i) Identify the contract, or contracts, with a customer (ii) Identify the performance obligations in the contract (iii) Determine the transaction price (iv) Allocate the transaction price to the performance obligations in the contract (v) Recognize revenue when the Company satisfies a performance obligation. The Company has not recognized any revenue since its inception. Related Party Balances and Transactions The Company follows FASB ASC 850, “ Related Party Disclosures Basic and Diluted Income (Loss) Per Share The Company computes income (loss) per share in accordance with FASB ASC 260, “Earnings per Share” which requires presentation of both basic and diluted earnings per share on the face of the statement of operations. Basic loss per share is computed by dividing net income (loss) available to common shareholders by the weighted average number of outstanding common shares during the period. Diluted income (loss) per share gives effect to all dilutive potential common shares outstanding during the period. Dilutive loss per share excludes all potential common shares if their effect is anti-dilutive. As of June 30, 2021 and 2020, the Company has no dilutive instruments. Recent accounting pronouncements In December 2019, the Financial Accounting Standards Board (FASB) issued Accounting Standard Update No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (ASU 2019-12), which simplifies the accounting for income taxes. This guidance will be effective for entities for the fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020 on a prospective basis, with early adoption permitted. We do not expect the adoption of this guidance to have a material impact on the Company’s financial statements. Management has considered all recent accounting pronouncements issued. The Company’s management believes that these recent pronouncements will not have a material effect on the Company’s financial statements.

GOING CONCERN

GOING CONCERN	9 Months Ended
GOING CONCERN	Jun. 30, 2021
GOING CONCERN
NOTE 3 - GOING CONCERN	NOTE 3 – GOING CONCERN The Company’s financial statements have been prepared assuming that it will continue as a going concern, which contemplates continuity of operations, realization of assets, and liquidation of liabilities in the normal course of business. As reflected in the financial statements, the Company had an accumulated deficit of $38,339, and working capital deficit of $11,559at June 30, 2021. These factors raise substantial doubt about the Company’s ability to continue as a going concern. The Company is attempting to commence operations and generate sufficient revenue; however, the Company’s cash position may not be sufficient to support the Company’s daily operations. Management intends to raise additional funds by way of a private or public offering. While the Company believes in the viability of its strategy to commence operations and generate sufficient revenue and in its ability to raise additional funds, there can be no assurances to that effect. The ability of the Company to continue as a going concern is dependent upon the Company’s ability to further implement its business plan and generate sufficient revenue and its ability to raise additional funds by way of a public or private offering. The financial statements do not include any adjustments related to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	9 Months Ended
RELATED PARTY TRANSACTIONS	Jun. 30, 2021
RELATED PARTY TRANSACTIONS
NOTE 4 - RELATED PARTY TRANSACTIONS	NOTE 4 – RELATED PARTY TRANSACTIONS The Company has received capital from the director of the Company to pay for the Company expenses. The advance is unsecured, non-interest bearing and due on demand. Former Director During the nine months ended June 30, 2021 and 2020, the Company incurred director consulting fees of $3,000 and $6,000 to the former director of the Company, respectively. Upon the resignation of the Company’s former director on March 31, 2021, the loan from the director of $10,832 and accrued consulting fees of $19,000 at the aggregate amount of $29,832 was forgiven. Current Director During the nine months ended June 30, 2021, the director of the Company made advancement of $10,154 for operating expenses of the Company. The advance is unsecured, non-interest bearing and due on demand.

STOCKHOLDERS EQUITY

STOCKHOLDERS EQUITY	9 Months Ended
STOCKHOLDERS EQUITY	Jun. 30, 2021
STOCKHOLDERS EQUITY
NOTE 5 - STOCKHOLDERS' EQUITY	NOTE 5 – STOCKHOLDERS’ EQUITY The Company has 75,000,000, $0.001 par value shares of common stock authorized. In March 2020, the Company issued 420,000 common shares to five shareholders as per subscription agreement at $0.01 per share for a total price of $4,200. In April and May 2020, the Company issued 2,228,000 of common shares as per subscription agreements at $0.01 per share for a total price of $22,280. As of June 30, 2021 and September 30, 2020, the Company had 5,648,000 shares issued and outstanding.

RISK AND UNCERTAINTIES

RISK AND UNCERTAINTIES	9 Months Ended
RISK AND UNCERTAINTIES	Jun. 30, 2021
RISK AND UNCERTAINTIES
NOTE 6 - RISK AND UNCERTAINTIES	NOTE 6 – RISK AND UNCERTAINTIES In early 2020, the World Health Organization declared the rapidly spreading coronavirus disease (COVID-19) outbreak a pandemic. This pandemic has resulted in governments worldwide enacting emergency measures to combat the spread of the virus. The Company considered the impact of COVID-19 on the assumptions and estimates used and determined that there were no retroactive material adverse impacts on the Company’s results of operations and financial position at June 30, 2021. The full extent of the future impacts of COVID-19 on the Company’s operations is uncertain. A prolonged outbreak could have a material adverse impact on financial results and business operations of the Company in the future. The Company is not 10 may

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	9 Months Ended
SUBSEQUENT EVENTS	Jun. 30, 2021
SUBSEQUENT EVENTS
NOTE 7 - SUBSEQUENT EVENTS	NOTE 7 – SUBSEQUENT EVENTS In accordance with ASC 855-10, the Company has analyzed its operations subsequent to June 30, 2021 to the date these financial statements were issued and has determined that it does not have any material subsequent events to disclose in these financial statements.

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	9 Months Ended
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	Jun. 30, 2021
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation	The accompanying unaudited interim financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included. Operating results for the nine months ended June 30, 2021 are not necessarily indicative of the results that may be expected for the year ending September 30, 2021. Notes to the unaudited interim financial statements that would substantially duplicate the disclosures contained in the audited financial statements for fiscal year 2020 have been omitted. This report should be read in conjunction with the audited financial statements and the footnotes thereto for the fiscal year ended September 30, 2020 included in the Company’s Form 10-K as filed with the Securities and Exchange Commission on November 20, 2020.
Development Stage Company	The Company is a development stage company as defined in ASC 915 “Development Stage Entities.” The Company is devoting substantially all of its efforts on establishing the business and its planned principal operations have not commenced. All losses accumulated since inception has been considered as part of the Company's development stage activities. The Company has elected to adopt application of Accounting Standards Update No. 2014-10, Development Stage Entities (Topic 915): Elimination of Certain Financial Reporting Requirements. Upon adoption, the Company no longer presents or discloses inception-to-date information and other remaining disclosure requirements of Topic 915.
Use of Estimates	The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Cash and Cash Equivalents	The Company considers all highly liquid investments with the original maturities of three months or less to be cash equivalents. During the year ended September 30, 2020, the Company entered a Trust Agreement with the director and set up Related Party Trust Account for holding funds in relation to issuing shares for stock consideration of $20,745. During the nine months ended June 30, 2021, all the funds held in escrow has been utilized and the Company did not have any fund held in the escrow account as of June 30, 2021.
Fair Value of Financial Instruments	ASC 820 “ Fair Value Measurements and Disclosures These tiers include: Level 1: defined as observable inputs such as quoted prices in active markets; Level 2: defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and Level 3: defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions. The carrying value of accounts payable and accrued liabilities, accrued interest, current portion of long-term debt, other party loan and loan from director approximates its fair value due to their short-term maturity.
Revenue Recognition	The Company recognizes revenue from its contracts with customers in accordance with ASC 606 – Revenue from Contracts with Customers. Revenue related to contracts with customers is evaluated utilizing the following steps: (i) Identify the contract, or contracts, with a customer (ii) Identify the performance obligations in the contract (iii) Determine the transaction price (iv) Allocate the transaction price to the performance obligations in the contract (v) Recognize revenue when the Company satisfies a performance obligation. The Company has not recognized any revenue since its inception.
Related Party Balances and Transactions	The Company follows FASB ASC 850, “ Related Party Disclosures
Basic and Diluted Income (Loss) Per Share	The Company computes income (loss) per share in accordance with FASB ASC 260, “Earnings per Share” which requires presentation of both basic and diluted earnings per share on the face of the statement of operations. Basic loss per share is computed by dividing net income (loss) available to common shareholders by the weighted average number of outstanding common shares during the period. Diluted income (loss) per share gives effect to all dilutive potential common shares outstanding during the period. Dilutive loss per share excludes all potential common shares if their effect is anti-dilutive. As of June 30, 2021 and 2020, the Company has no dilutive instruments.
Recent accounting pronouncements	In December 2019, the Financial Accounting Standards Board (FASB) issued Accounting Standard Update No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (ASU 2019-12), which simplifies the accounting for income taxes. This guidance will be effective for entities for the fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020 on a prospective basis, with early adoption permitted. We do not expect the adoption of this guidance to have a material impact on the Company’s financial statements. Management has considered all recent accounting pronouncements issued. The Company’s management believes that these recent pronouncements will not have a material effect on the Company’s financial statements.

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)	Jun. 30, 2021USD ($)
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Cash balance	$ 20,745

GOING CONCERN (Details Narrativ

GOING CONCERN (Details Narrative) - USD ($)	Jun. 30, 2021	Sep. 30, 2020
GOING CONCERN
Accumulated deficit	$ (38,339)	$ (32,867)
Working capital deficit	$ (11,559)

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)	9 Months Ended
RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)	Jun. 30, 2021	Jun. 30, 2020	Mar. 31, 2021
Proceeds from director loan	$ 10,154	$ 8,609
Directors [Member]
Proceeds from director loan	10,154
Consulting fees	3,000	$ 6,000
Accrued consulting fees			$ 19,000
Forgiveness of loans	$ 29,832
Loan from related party			$ 10,832

STOCKHOLDERS EQUITY (Details Na

STOCKHOLDERS EQUITY (Details Narrative) - USD ($)	9 Months Ended
STOCKHOLDERS EQUITY (Details Narrative) - USD ($)	Jun. 30, 2021	Sep. 30, 2020
Common shares authorized	75,000,000	75,000,000
Par value of common shares	$ 0.0001	$ 0.0001
Common shares issued	5,648,000	5,648,000
Common shares outstanding	5,648,000	5,648,000
Subscription Agreement [Member] \| March 2020 [Member]
Shares issued for cash, shares	420,000
Shares issued for cash, value	$ 4,200
Price per share	$ 0.01
Subscription Agreement [Member] \| April and May 2020 [Member]
Shares issued for cash, shares	2,228,000
Shares issued for cash, value	$ 22,280
Price per share	$ 0.01